Psychiatry and Neurology, Neurology · Mobile, AL
NPI
1699086199
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1720 Spring Hill Ave, 3rd Floor
Mobile, AL, 36604
Phone (251) 435-1200
Groups this clinician bills Medicare through
Medicare paid, 2024
$117K
13,275 services
Medicare patients, 2024
412
Average age 74
Drug cost, 2024
$2.7M
4,728 prescriptions
Company payments, 2025
$3,062
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew S McLean was code J0585 (injection, onabotulinumtoxina, 1 unit), 9,755 times for 16 patients. In total Matthew S McLean billed 13,275 services in 48 codes, and Medicare paid $117K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 9,755 | 16 | $4.77 | $47K |
| 99213 Office E&M - Established | Office | 247 | 180 | $54.72 | $14K |
| 99214 Office E&M - Established | Office | 177 | 133 | $82.88 | $15K |
| 36415 Venipuncture Blood Collection | Office | 90 | 86 | $8.65 | $779 |
| 95816 Neurologic | Facility | 88 | 85 | $40.86 | $3,595 |
| 99204 Office E&M - New | Office | 63 | 63 | $105.90 | $6,672 |
| 82607 Clinical Chemistry | Office | 34 | 34 | $14.78 | $503 |
| 82746 Clinical Chemistry | Office | 33 | 33 | $14.41 | $476 |
| 95819 Neurologic | Facility | 33 | 28 | $41.08 | $1,356 |
| 99215 Office E&M - Established | Office | 27 | 27 | $115.64 | $3,122 |
| 84439 Clinical Chemistry | Office | 24 | 24 | $8.84 | $212 |
| 84443 Clinical Chemistry | Office | 24 | 24 | $16.46 | $395 |
| 95886 Electrical Nerve Conductivity | Office | 23 | 21 | $65.52 | $1,507 |
| 85652 Clinical Chemistry | Office | 23 | 23 | $2.65 | $60.95 |
| 86140 Clinical Chemistry | Office | 23 | 23 | $5.08 | $117 |
By year: 2022 $164K for 19,445 services; 2023 $148K for 17,434 services; 2024 $117K for 13,275 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 90 | 86 | $8.65 | $779 |
| 82607 Clinical Chemistry | 34 | 34 | $14.78 | $503 |
| 82746 Clinical Chemistry | 33 | 33 | $14.41 | $476 |
| 84443 Clinical Chemistry | 24 | 24 | $16.46 | $395 |
| 84439 Clinical Chemistry | 24 | 24 | $8.84 | $212 |
| 85652 Clinical Chemistry | 23 | 23 | $2.65 | $60.95 |
| 86140 Clinical Chemistry | 23 | 23 | $5.08 | $117 |
| 86431 Immunoassay | 17 | 17 | $5.56 | $94.52 |
| 80053 Clinical Chemistry | 16 | 14 | $10.35 | $166 |
| 85025 Blood Count | 16 | 14 | $7.61 | $122 |
Medicare prescription drug claims, 2024
In 2024, the drug Matthew S McLean prescribed most often to Medicare patients was Gabapentin, with 381 prescriptions and refills. In total Matthew S McLean wrote 4,728 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 381 | 666 | 106 | $6,855 |
| Donepezil Hcl Generic | 380 | 838 | 128 | $3,172 |
| Memantine Hcl Generic | 308 | 617 | 86 | $9,854 |
| Levetiracetam Generic | 255 | 597 | 70 | $7,465 |
| Pregabalin Generic | 190 | 336 | 46 | $5,147 |
| Topiramate Generic | 187 | 408 | 53 | $2,163 |
| Clonazepam Generic | 152 | 174 | 27 | $729 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 111 | 226 | 33 | $4,416 |
| Primidone Generic | 104 | 261 | 30 | $4,034 |
| Duloxetine Hcl Generic | 98 | 197 | 27 | $2,087 |
| Lacosamide Generic | 97 | 155 | 19 | $8,988 |
| Tizanidine Hcl Generic | 95 | 142 | 30 | $958 |
| Sumatriptan Succinate Generic | 93 | 107 | 19 | $1,230 |
| Propranolol Hcl Er Propranolol Hcl | 86 | 187 | 24 | $4,607 |
| Amitriptyline Hcl Generic | 81 | 135 | 22 | $1,379 |
Brand drugs: 524 claims; generic drugs: 4,192 claims; opioid claims: 78.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew S McLean $3,062 ($3,062 in general payments such as food, travel and fees) from 27 companies. The largest payer was Abbvie Inc. with $630.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.